BRCA2 and breast carcinoma: Therefore, the frequency of BRCA2 PV carriers among women with breast cancer might have been underestimated, because the family history of breast and ovarian cancer is less marked, and breast or ovarian cancers are less penetrant or delayed in lifetime.